Report on post-transplantation cancer in southeast Asia from the Thai kidney transplantation cohort
Scientific Reports · 2024
DOI: 10.1038/s41598-024-71041-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Scientific Reports, 2024. Verfasst von Suthanit Laowalert und 10 weiteren Autor:innen. Beteiligte Einrichtung: Kidney Transplant Institute, Praram 9 Hospital, Bangkok, Thailand. Hauptthemen laut MEDLINE: Kidney Transplantation, Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Post-transplantation cancer is a significant cause of mortality among kidney transplant recipients (KTR). The incidence of post-transplantation cancer varies based on geographic region and ethnicity. However, data on KTR from South East Asia, where characteristics differ from other parts of Asia, is lacking. We conducted a retrospective cohort study at a transplant center in Thailand to investigate the incidence of post-transplantation cancer and mortality rates. Factors associated with post-transplantation cancer and patient outcomes were analyzed using competing-risks regression. The study included 1156 KTR with a post-transplant follow-up duration of 5.1 (2.7-9.4) years. The age- and sex-adjusted incidence rate of post-transplant cancer was highest for urothelial cancer (6.9 per 1000 person-years), which also resulted in the highest standardized incidence ratio (SIR) of 42.5 when compared to the general population. Kidney cancer had the second-highest SIR of 24.4. Increasing age was the factor associated with an increased risk of post-transplant cancer (SHR 1.03; 95% CI 1.01-1.05). Human leukocyte antigen (HLA) DR mismatch was associated with a decreased risk of post-transplant cancer (SHR 0.72; 95% CI 0.52-0.98). Post-transplantation cancer was significantly associated with patient mortality (HR 3.16; 95% CI 2.21-4.52). Cancer significantly contributes to KTR mortality, and the risk profile for cancer development in Thai KTRs differs from that of Western and most Asian counterparts. Further research is essential to explore appropriate screening protocols for countries with high rates of urothelial and kidney cancer, including Thailand.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Kidney Transplant Institute, Praram 9 Hospital, Bangkok, Thailand.
- Division of Nephrology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, 1873, Rama 4 Road, Pathumwan, 10330, Bangkok, Thailand. suwasi…
Zitieren
APA
Laowalert, S., Naitook, N., Boonnim, K., Prungrit, U., Aekkachaipitak, N., Lamjantuek, P., Liwlompaisan, W., Khunprakant, R., Techawathanawanna, N., Mavichak, V., & Udomkarnjananun, S. (2024). Report on post-transplantation cancer in southeast Asia from the Thai kidney transplantation cohort. Scientific Reports. https://doi.org/10.1038/s41598-024-71041-x
Vancouver
Laowalert S, Naitook N, Boonnim K, Prungrit U, Aekkachaipitak N, Lamjantuek P, et al. Report on post-transplantation cancer in southeast Asia from the Thai kidney transplantation cohort. Scientific Reports. 2024. doi:10.1038/s41598-024-71041-x
BibTeX
@article{Laowalert2024,
author = {Laowalert, Suthanit and Naitook, Nattakan and Boonnim, Kesawan and Prungrit, Uayporn and Aekkachaipitak, Nidjaree and Lamjantuek, Pornpawee and Liwlompaisan, Wisit and Khunprakant, Rungrote and Techawathanawanna, North and Mavichak, Viroon and Udomkarnjananun, Suwasin},
title = {Report on post-transplantation cancer in southeast Asia from the Thai kidney transplantation cohort},
journal = {Scientific Reports},
year = {2024},
doi = {10.1038/s41598-024-71041-x}
}
EUVIMED